The DEA position as of July 2017 on the Schedule I status of cannabidiol oil, aka CBD oil or Charlotte's Web, in a statement on hemp and the Farm Bill. It is the first time the agency has lowered any type of cannabis from Schedule 1. The action came three months after the FDA approved its first nonsynthetic, cannabis-derived medicine, a CBD preparation for rare types of epilepsy. The drug, Epidiolex, is made from cannabis grown in the United Kingdom. The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. The agency announced Thursday that drugs including finished dosage formulations of CBD with THC below 0.1% will. Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds This is a huge move for CBD producers and marks the first time the agency has lowered any type of cannabis from Schedule 1. The declassification from schedule 1 suggests that the DEA recognizes that cannabis has medical value. And this is big news! CBD a Schedule 5 Drug. The announcement was made yesterday and marks a changing point for. It's now a Schedule 1 drug. Now a Schedule 1 Drug: CBD Hemp Oil New DEA regulation may affect those who use it to treat seizures, other medical issues By Jenn Gidman, Newser Staff Posted Dec. FDA approved Epidiolex (cannabidiol) oral solution, the first drug comprised of an active ingredient derived from marijuana, to treat two rare and severe forms of epilepsy. A Schedule 1 drug – which CBD is not classified as – is considered to have the MOST potential for abuse and addiction, and no accepted medical purpose. It’s now considered on the same level as heroin, which takes over 42,000 American lives annually from overdose. CBD producers and company owners are committed to overturning this decision. What does that mean for the industry? Is CBD oil a Schedule 1 substance? Let’s take a look. Has CBD Really Been Rescheduled? The U.S. Drug Enforcement Administration announced that drugs that contain CBD with THC content below 0.1% are not considered Schedule I drugs, as long as they have been approved by the FDA. The DEA’s move to classify CBD oil as a Schedule 1 drug is documented in the Federal Register, where the official ruling, in essence, suggests that the substance is as illegal as traditional whole-plant marijuana.